Introduction: A New Frontier at the Intersection of Psychedelics and Sport

The world of elite athletics is constantly searching for an edge—a mental breakthrough, a recovery advantage, or a way to shed inhibitions without sacrificing control. In recent years, the conversation around psychedelics and performance has moved from fringe subcultures into mainstream sports science. Among the compounds drawing attention is lysergic acid diethylamide (LSD), a substance once central to the counterculture of the 1960s and now being reexamined through a modern, clinical lens.

Traditionally associated with profound alterations in perception, thought, and emotion, LSD is being studied for its potential to influence mental resilience, focus, and even pain management. While the idea of an athlete using a psychedelic to enhance performance may seem paradoxical—given the chaotic and unpredictable nature of the experience—some researchers and athletes are beginning to ask whether very low doses (so-called microdoses), or carefully controlled higher-dose sessions, could offer benefits without the overwhelming hallucinogenic effects. However, the scientific evidence remains sparse, and legal, ethical, and safety concerns dominate the discussion.

This article explores the latest research on LSD and athletic performance, separates anecdotal claims from controlled data, and provides a balanced view of what scientists, coaches, and athletes need to consider before any meaningful conclusions can be drawn.

Understanding the Pharmacology of LSD

To evaluate its potential role in sports, it is essential to understand how LSD works in the brain and body. LSD is a serotonergic psychedelic, meaning its primary mode of action is through agonism of the serotonin 2A (5-HT2A) receptors. This interaction triggers a cascade of neural activity that alters communication between brain regions, particularly the default mode network (DMN)—a set of interconnected areas associated with self-referential thought, ego, and rumination.

When the DMN is dampened, the brain becomes less rigid in its patterns. New connections can form, sensory information is processed differently, and users often report heightened awareness, emotional openness, and a sense of unity. These effects are dose-dependent. A typical recreational dose of 100–200 micrograms can produce vivid hallucinations, time distortion, and ego dissolution lasting 8–12 hours. In contrast, a microdose—usually 5–20 micrograms—is believed to be sub-perceptual, meaning the user does not experience obvious visual or mental changes but may feel subtle improvements in mood, creativity, or energy.

Beyond the central nervous system, LSD also affects the peripheral system. Heart rate, blood pressure, and body temperature can increase during the acute phase. These physiological changes raise immediate red flags for athletic application, as any substance that taxes the cardiovascular system during exercise carries inherent risk. The long-lasting nature of LSD—up to 12 hours—further complicates its use in training or competition contexts where timing and predictability are critical.

Historical Context: Psychedelics and the Origins of Sports Science Interest

The current interest in LSD and athletic performance is not entirely new. In the 1950s and early 1960s, before LSD was made illegal in most countries, several researchers explored its potential in physical and creative domains. One notable figure was Al Hubbard, a Canadian businessman and early psychedelic advocate who reportedly provided LSD to athletes, executives, and artists, claiming it enhanced mental clarity and physical drive. While these claims were largely anecdotal and lacked rigorous controls, they planted a seed that has only recently resurfaced.

During the same period, the U.S. government and military experimented with LSD for interrogation and performance enhancement, though results were inconsistent and often negative. As recreational use spread and adverse events became public, LSD was classified as a Schedule I substance in the United States in 1970, effectively halting most research. For decades, the scientific community largely abandoned the study of psychedelics for performance.

Only in the last ten years has a renaissance in psychedelic research—for mental health conditions such as depression, PTSD, and addiction—reopened the door to exploring broader applications. Athletes, particularly in extreme sports and endurance disciplines, have begun sharing personal accounts of using psychedelics (including LSD) to overcome mental blocks, reduce performance anxiety, or achieve a state of flow. These anecdotal reports, while compelling, must be weighed against the lack of controlled trials.

Current Research Landscape: What the Science Actually Shows

As of 2025, no large-scale, double-blind, placebo-controlled studies have directly examined LSD’s effect on athletic performance. The body of evidence consists of a handful of small human trials focused on mental health, observational studies on microdosing, and a growing number of rodent experiments using forced swim tests and locomotion tasks.

Human Trials: Cognitive and Emotional Outcomes

Recent clinical trials—such as those conducted at Imperial College London, Johns Hopkins University, and the Beckley Foundation—have primarily investigated LSD’s therapeutic potential. These studies have shown that LSD can reduce anxiety, increase optimism, and promote neuroplasticity. For example, a 2022 randomized controlled trial published in Biological Psychiatry found that a single moderate dose of LSD (100 mcg) reduced anxiety in patients with life-threatening illness and produced lasting improvements in well-being. While not athletic-performance-specific, these psychological outcomes—reduced anxiety and improved mood—have clear relevance to competitive training.

A smaller observational study on microdosing (using self-reported data) reported improvements in focus, creativity, and energy. However, the placebo effect is notoriously strong in psychedelic research, and critics argue that most microdosing benefits can be attributed to expectation rather than pharmacology. A landmark 2021 study by Balázs Szigeti and colleagues used an active placebo design and found that participants’ subjective improvements from microdosing were indistinguishable from placebo. This does not rule out potential benefits, but it underscores the need for rigorous designs that control for belief.

Animal Research: Physical Performance Measures

Rodent studies provide some clues. In a 2019 study, mice given low doses of LSD showed increased voluntary wheel running activity and greater endurance in forced swim tests, suggesting possible motor activation or motivational effects. However, other rodent studies have shown impaired coordination and increased risk-taking. Translating these results to humans is problematic due to differences in metabolism, brain structure, and the uniquely human psychological context of sport. Animal models cannot replicate the complex mental facets of competitive athletic performance, such as strategy, decision-making under pressure, and teamwork.

A 2019 study on LSD and physical activity in mice (Nature Scientific Reports) is an example of the type of foundational research being done, but its implications for human athletes remain speculative.

Potential Benefits: Mechanisms and Anecdotes

Despite the lack of direct evidence, several hypothetical mechanisms have been proposed for how LSD could influence athletic performance. These possibilities remain speculative but are worth examining, as they guide future research directions.

Enhanced Focus and Flow State

Athletes often describe a flow state—a zone of total immersion in the task, where self-consciousness fades and actions feel effortless. Neuroimaging studies show that during flow, the DMN is quieted. LSD also suppresses the DMN. This overlap suggests that, at the right dose, LSD might help induce or prolong a flow state. Anecdotally, some sprinters and mountain bikers have reported that microdoses helped them achieve extended periods of concentration without distraction.

Reduction of Performance Anxiety

Performance anxiety is a major barrier to optimal performance in many sports, from gymnastics to golf. LSD’s well-documented anxiolytic effects (in clinical contexts) could theoretically help athletes relax before competition without the sedation associated with benzodiazepines. However, the risk of a full-blown psychedelic experience at higher doses outweighs any minor benefit. Microdosing might offer a less risky path, but the evidence for anxiolytic effects at microdoses is inconsistent.

Pain Perception and Recovery

Some athletes speculate that LSD could modify pain perception, allowing them to push past discomfort during training or rehabilitation. Pain is a complex experience involving both sensory and emotional components. Psychedelics can separate the emotional reaction from the physical sensation, a phenomenon sometimes described as “pain detachment.” A 2023 review in Neuropharmacology noted that psychedelics may reduce pain-related distress, but the evidence is preliminary and primarily from case studies with psilocybin or LSD in patients with chronic pain. No studies have examined acute pain during exercise.

A review on psychedelics and pain in Neuropharmacology highlights the current state of understanding.

Neuroplasticity and Recovery from Injury

LSD and other psychedelics have been shown to promote neuroplasticity—the brain’s ability to reorganize and form new neural connections. This could be relevant for athletes recovering from brain injuries, strokes, or even psychological trauma from intense competition. A 2018 study found that a single dose of LSD increased the expression of brain-derived neurotrophic factor (BDNF) in the human brain, which is associated with learning and memory. Whether this translates to faster motor-skill learning or rehabilitation remains unknown.

Major Risks and Concerns: The Unpredictable and the Prohibited

The potential benefits must be weighed against significant risks that make any recommendation or use of LSD in athletic settings highly problematic.

Unpredictable Psychological Effects

Even at supposedly sub-perceptual microdoses, some people experience disruptive perceptual changes, anxiety, or emotional instability. A full dose can cause a bad trip—an experience of fear, paranoia, or overwhelming confusion. In the context of a competition or intense training session, such a reaction could lead to panic, injury, or dangerous behavior. The effects are highly dependent on set (mindset) and setting (environment), which are difficult to control in a high-stakes athletic environment.

Physical Health Risks

LSD increases heart rate and blood pressure. For athletes with underlying cardiovascular conditions—which are not always diagnosed—this could precipitate arrhythmias or even cardiac events. Heat-related illness is also a concern, as LSD can interfere with thermoregulation. Dehydration or electrolyte imbalances, common in endurance sports, could be exacerbated.

Hallucinogen Persisting Perception Disorder (HPPD)

Although rare, some users develop HPPD, a condition characterized by persistent visual disturbances (like floaters, trailing images, or flickering lights) after the drug has worn off. This could impair visual-spatial coordination required in many sports, particularly those involving fast-moving balls or precise motor control.

LSD is classified as a Schedule I substance under U.S. federal law and is illegal in most countries around the world. The World Anti-Doping Agency (WADA) prohibits LSD at all times, both in and out of competition. It appears on the WADA Prohibited List under substances with no current approved medical use. Athletes found to have LSD in their system face sanctions ranging from public warnings to multi-year bans. Even in jurisdictions where psychedelics are being decriminalized (e.g., Oregon, some European cities), sports governing bodies operate under their own strict rules.

The current WADA Prohibited List includes all classes of psychedelics.

The Placebo Effect and the Power of Belief

Any discussion of LSD and performance must acknowledge the strong placebo response observed in psychedelic research. Many users report profound benefits from microdosing, but controlled trials consistently show that most of these benefits—improved mood, focus, creativity—are largely reproduced by placebo. The act of taking a pill, the ritual of it, and the expectation of a positive outcome can be a powerful performance enhancer in itself. This does not mean the benefits are “fake,” but it means they may not be pharmacologically derived from LSD. For athletes, this raises an ethical and practical question: can a placebo provide a legal and safe edge without the risks of an illegal substance?

In fact, some proponents of microdosing now argue that the primary benefit is the ritual and intention-setting, not the drug. For coaches and sport psychologists, this suggests that non-pharmacological interventions—meditation, breathing exercises, visualization—might deliver similar outcomes without legal risk.

Future Directions and Research Needs

To move beyond anecdote and controversy, rigorous scientific investigation is needed. The following gaps must be addressed:

  • Controlled human performance studies: Double-blind, placebo-controlled trials using standardized athletic tasks (e.g., time trials, reaction time tests, endurance protocols) with microdoses and moderate doses.
  • Dose-response data: Understanding the optimal dose window that separates risk from potential benefit for psychological variables like focus and anxiety.
  • Cardiovascular safety during exercise: Studies examining heart rate, blood pressure, and thermoregulation when LSD is combined with physical exertion.
  • Long-term effects on brain health: Whether repeated microdosing alters neural connectivity in ways that could help or hinder motor learning.
  • Comparison with non-pharmacological methods: Head-to-head trials comparing microdosing to mindfulness training or biofeedback for performance enhancement.

Some of this research is already underway. The Psychedelic Research Group at Imperial College London, the Johns Hopkins Center for Psychedelic and Consciousness Research, and the Multidisciplinary Association for Psychedelic Studies (MAPS) are expanding their focus to include peak performance and creativity. MAPS maintains an active research portfolio that may eventually include athletic applications.

Ethical Considerations and the Slippery Slope

Even if future research shows that LSD can enhance performance, a host of ethical questions will remain. Should athletes be allowed to use a substance that alters brain function to gain a competitive advantage? Where is the line between therapeutic use (e.g., treating PTSD from a sports injury) and enhancement? Psychedelics may offer genuine psychological breakthroughs, but their use in sport could also set a slippery slope where athletes feel pressured to use mind-altering drugs to keep up with peers, much as the pandemic of doping in endurance sports occurred with EPO.

Furthermore, the subjective nature of psychedelic experiences makes them difficult to standardize. Two athletes taking the same dose could have wildly different outcomes—one might achieve a state of calm focus, the other a panic attack. This unpredictability is incompatible with the demand for reliable performance.

Conclusion: Proceed with Caution, Embrace Evidence

The latest research on LSD and athletic performance is nascent, suggestive, but far from conclusive. While there are plausible mechanisms—enhanced focus, reduced anxiety, neuroplasticity—through which LSD could influence athletic outcomes, the evidence is largely anecdotal and limited by small sample sizes, lack of controls, and powerful placebo effects. The risks, both legal and physical, are substantial. WADA bans the substance, and most medical professionals would advise against its use for performance enhancement.

Athletes and coaches seeking an edge should prioritize proven, safe methods: evidence-based training programs, sleep optimization, nutrition, sports psychology, and mental skills training. As the research evolves, it is possible that some psychedelic compounds—or their derivatives—may find a legitimate place in sports medicine, particularly for mental health support or neuro-rehabilitation after injury. But for now, the science does not support using LSD to enhance athletic performance.

The future will depend on rigorous, ethical studies that can untangle the complex interplay between pharmacology, mindset, and physical output. Until then, the intersection of LSD and sports remains a fascinating question mark—one that deserves open inquiry but demands strict caution.